Faron selected for EUR2.5 million grant from EIC
Faron selected for €2.5 million grant from European Innovation Council Accelerator pilot for MATINS study accelerationCompany announcement, 11 June 2020 at 09.00 AM (EET) Inside Information TURKU – FINLAND Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces today that, it has been selected to receive a €2.5 million grant from the European Innovation Council (EIC) Accelerator pilot scheme to progress the MATINS Study and related business activities. The EIC Accelerator pilot scheme supports top-class innovators,